Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion type Assertion NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_head.
- NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated rhabdoid predisposition syndrome. In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_provenance.
- NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion evidence source_evidence_literature NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_provenance.
- NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion SIO_000772 11547953 NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_provenance.
- NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion wasDerivedFrom befree-2016 NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_provenance.
- NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion wasGeneratedBy ECO_0000203 NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_provenance.